<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39342170</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC pediatrics</Title><ISOAbbreviation>BMC Pediatr</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics and outcomes of neonatal SARS-CoV-2 infection after the release of the epidemic situation of COVID-19.</ArticleTitle><Pagination><StartPage>616</StartPage><MedlinePgn>616</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">616</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12887-024-05096-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">With the release of the coronavirus disease 2019 (COVID-19) pandemic in late 2022 in China, the number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) roared, including neonatal cases. However, there were few studies on neonatal COVID-19, especially multi-center case reports. This study aimed to explore clinical characteristics and short-term outcomes of neonatal COVID-19 in China.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed 187 cases of neonatal COVID-19 between December 11, 2022, and January 12, 2023. The diagnosis was assessed by symptoms, laboratory tests, X-ray manifestations, and diagnosis code. Clinical characteristics and outcomes were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 187 neonatal cases with COVID-19, 84 (44.9%) had severe SARS-CoV-2 infection. Most patients had confirmed exposure to SARS-CoV-2. Fever and respiratory symptoms were common (75.4% and 71.7%, respectively). Severe patients were more likely to have high alanine transaminase (ALT) (&gt; 40U/L) (11.9% vs. 3.9%) and high N-terminal pro-brain natriuretic peptide (NT-proBNP) (&gt; 2000pg/mL) (38.0% vs. 19.6%), compared with nonsevere ones (P &lt; 0.05). None of the patients received COVID-19-specific medical interventions. A few severe patients received corticosteroids (1.1%), and immunoglobulin (0.5%), respectively. All patients were discharged home after the medical care with a median length of stay (LOS) of four days and none of them met the criteria of multisystem inflammatory syndrome in neonates (MIS-N).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After the release of the epidemic situation of COVID-19 in late 2022 in China, more neonatal cases with severe COVID-19 had high ALT and NT-proBNP level. Few specific medical interventions were given, and the outcome was satisfying.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xia</LastName><ForeName>Siyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Xinhua Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bei</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cai</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Liqing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Jiaxing Maternity and Child Health Care Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Xinhua Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Huafei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Jiaxing Maternity and Child Health Care Hospital, Shanghai, China. huanghuafei@aliyun.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Hongping</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Xinhua Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. xiahongping@xinhuamed.com.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202340047</GrantID><Agency>Shanghai Municipal Health Commission</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pediatr</MedlineTA><NlmUniqueID>100967804</NlmUniqueID><ISSNLinking>1471-2431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">N-terminal pro-brain natriuretic peptide</Keyword><Keyword MajorTopicYN="N">Neonate</Keyword><Keyword MajorTopicYN="N">Severe</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39342170</ArticleId><ArticleId IdType="pmc">PMC11437735</ArticleId><ArticleId IdType="doi">10.1186/s12887-024-05096-0</ArticleId><ArticleId IdType="pii">10.1186/s12887-024-05096-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scovino AM, Dahab EC, Vieira GF, Freire-de-Lima L, Freire-de-Lima CG, Morrot A. SARS-CoV-2’s variants of concern: a brief characterization. Front Immunol. 2022;13:834098. 10.3389/fimmu.2022.834098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9361785</ArticleId><ArticleId IdType="pubmed">35958548</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–5. 10.1038/s41586-020-2918-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim LF, Tham D, Chong V, Corden M, Craig S, Buntine P, et al. The characteristics of SARS-CoV-2-positive children who presented to Australian hospitals during 2020: a PREDICT network study. Med J Aust. 2021;215(5):217–21. 10.5694/mja2.51207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447363</ArticleId><ArticleId IdType="pubmed">34389995</ArticleId></ArticleIdList></Reference><Reference><Citation>Devin J, Marano R, Mikhael M, Feaster W, Sanger T, Ehwerhemuepha L. Epidemiology of neonatal COVID-19 in the United States. Pediatrics. 2022;150(4):e2022056297. 10.1542/peds.2022-056297.</Citation><ArticleIdList><ArticleId IdType="pubmed">35996224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale C, Quigley MA, Placzek A, Knight M, Ladhani S, Draper ES, et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc Health. 2021;5(2):113–21. 10.1016/S2352-4642(20)30342-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818530</ArticleId><ArticleId IdType="pubmed">33181124</ArticleId></ArticleIdList></Reference><Reference><Citation>Shook LL, Collier AY, Goldfarb IT, Diouf K, Akinwunmi BO, Young N, et al. Vertical transmission of SARS-CoV-2: consider the denominator. Am J Obstet Gynecol MFM. 2021;3(4):100386. 10.1016/j.ajogmf.2021.100386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081748</ArticleId><ArticleId IdType="pubmed">33932627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallem VR, Sharma D. COVID 19 in neonates. J Matern Fetal Neonatal Med. 2022;35(8):1610–8. 10.1080/14767058.2020.1759542.</Citation><ArticleIdList><ArticleId IdType="pubmed">32419544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaei R, Pezeshki S, Parvaresh S, Sinaei R, Why. COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2021;17(1):10–20. 10.1007/s12519-020-00392-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518650</ArticleId><ArticleId IdType="pubmed">32978651</ArticleId></ArticleIdList></Reference><Reference><Citation>Halasa NB, Olson SM, Staat MA, Newhams MM, Price AM, Pannaraj PS, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. 2022;387(2):109–19. 10.1056/NEJMoa2204399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9342588</ArticleId><ArticleId IdType="pubmed">35731908</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N, Wu YF, Chen YW, Fang XY, Zhou M, Wang WY, et al. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children’s medical center in Shanghai, China. World J Pediatr. 2023;19(1):87–95. 10.1007/s12519-022-00621-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574794</ArticleId><ArticleId IdType="pubmed">36251118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy VV, Abiramalatha T, Pullattayil SAK, Trevisanuto D. Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19. Semin Fetal Neonatal Med. 2023;28(2):101431. 10.1016/j.siny.2023.101431.</Citation><ArticleIdList><ArticleId IdType="pubmed">37061425</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao J, Hu XC, Fan MX, Chen J, Cheng QR, Li Z, et al. Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of COVID-19. World J Pediatr. 2022;18(5):343–9. 10.1007/s12519-022-00529-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918891</ArticleId><ArticleId IdType="pubmed">35287229</ArticleId></ArticleIdList></Reference><Reference><Citation>ELBAYİYEV S, YILMAZ N, ŞİMŞEK GK, KUTMAN TURGUTE. Comparative evaluation of systemic Immune indexes in infants born to COVID-19 PCR positive and negative mothers - can neonatal effects be predicted? Namik Kemal Med J. 2022;10(2):169–74. 10.4274/nkmj.galenos.2022.59672.</Citation></Reference><Reference><Citation>Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel systemic inflammation markers to Predict COVID-19 prognosis. Front Immunol. 2021;12:741061. 10.3389/fimmu.2021.741061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569430</ArticleId><ArticleId IdType="pubmed">34745112</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J. China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–9. 10.1001/jamainternmed.2020.2033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Li H, Zhang C, Chen Z, Liu H, Lei F, et al. The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19. Cell Metab. 2021;33(2):258–e2693. 10.1016/j.cmet.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832609</ArticleId><ArticleId IdType="pubmed">33421384</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–47. 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams P, Koirala A, Saravanos GL, Lopez LK, Glover C, Sharma K, et al. COVID-19 in New South Wales children during 2021: severity and clinical spectrum. Med J Aust. 2022;217(6):303–10. 10.5694/mja2.51661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349636</ArticleId><ArticleId IdType="pubmed">35851698</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu GB, Gu Y, Wang YW, Wang CQ, Ma J, Zeng M, et al. Clinical experiences in the management of critically ill patients with COVID-19 in a designated children’s hospital in China. World J Pediatr. 2023;19(6):605–8. 10.1007/s12519-023-00718-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10105610</ArticleId><ArticleId IdType="pubmed">37061567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraile Navarro D, Tendal B, Tingay D, Vasilunas N, Anderson L, Best J, et al. Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 clinical evidence taskforce. Med J Aust. 2022;216(5):255–63. 10.5694/mja2.51305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661691</ArticleId><ArticleId IdType="pubmed">34689329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>